United Kingdom
UK / English
Choose your region
Choose your language
Register
Mast_Group.svg
ProductsMarketsAboutResourcesNews & Events
Contact us
ProductsMarketsAboutResourcesNews & Events
logo-mast.svg
+44 (0) 151 933 7277
Email us
Sign up to Newsletter
Products
  • Gastrointestinal Diseases
  • Immunology
  • Microbiology
  • Molecular
  • Pharmaceutical Services
  • Urinalysis
Markets
  • Clinical Diagnostics
  • FIT testing
  • Infectious Disease
  • Pharmaceutical & Industrial
  • Point of Care
  • Veterinary
About
  • Careers
  • Our Culture
  • Our Governance
  • Our History
  • Our Locations
  • Our Partners
  • Our Quality
Resources
  • Faqs
  • Certificates of Analysis
  • Quality Certification
News & Events
  • News
  • Events
  • Blog
United Kingdom
UK / English
Manage Cookies|
Terms & conditions|
Privacy and Data Protection|
Policy Ordering Information|
Terms and Conditions For Supply of Goods and/or Services|
Standard Conditions of Purchase
|© Mast Group Ltd. 2026
Follow Us
LinkedIn.svgUK
© Mast Group Ltd. 2026
Home
ADATAB®TAB/FC0.2
TAB/FC0.2

Fusidic Acid 0.2mg

Enquire now
MAST® ADATAB® is a lyophilised tablet designed for rapid preparation of antibiotic-supplemented agar plates for breakpoint or MIC susceptibility testing of clinical bacteria. Each tablet contains an exact antibiotic dose to produce the required breakpoint concentration in 100 ml of medium. Key benefits include: Reproducible, accurate, easy to interpret, control strains can be included on the same plate and no weighing or dilution required.
Pack Size
25 x 100ml Tablets
Status
Stock
Commodity Code
38229000
Pack Size
Pack Size
25 x 100ml Tablets
CE
CE
✗
Storage Temperature
Storage Temperature
2 to 8˚C

Resources